ORKA Oruka Therapeutics Inc.

Price (delayed)

$62.49

Market cap

$3.77B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.94

Enterprise value

$3.72B

?
Relative Growth: Rel. Growth: 13
Relative Strength: Rel. Strength: 97
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 8
Highlights
The company's equity rose by 33% YoY and by 3.1% QoQ
The company's debt has surged by 91% YoY but it fell by 6% QoQ
Oruka Therapeutics's EPS has soared by 71% YoY but it has decreased by 4.9% from the previous quarter
Oruka Therapeutics's net income has decreased by 19% YoY and by 10% QoQ

Key stats

What are the main financial stats of ORKA

ORKA stock price

How has the Oruka Therapeutics stock price performed over time
Intraday
9.25%
1 week
7.78%
1 month
-5.97%
1 year
435.02%
YTD
106.17%
QTD
27.4%

Financial performance

How have Oruka Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$133.4M
Net income
-$116.25M
Gross margin
N/A
Net margin
N/A
ORKA's operating income is down by 25% year-on-year and by 9% since the previous quarter
Oruka Therapeutics's net income has decreased by 19% YoY and by 10% QoQ

Price vs fundamentals

How does ORKA's price correlate with its fundamentals

Growth

What is Oruka Therapeutics's growth rate over time

Valuation

What is Oruka Therapeutics stock price valuation
P/E
N/A
P/B
6.36
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Oruka Therapeutics's EPS has soared by 71% YoY but it has decreased by 4.9% from the previous quarter
ORKA's price to book (P/B) is 116% higher than its last 4 quarters average of 2.7 but 99% lower than its 5-year quarterly average of 1154.0
The company's equity rose by 33% YoY and by 3.1% QoQ

Efficiency

How efficient is Oruka Therapeutics business performance
Oruka Therapeutics's return on invested capital has surged by 54% YoY
The return on equity has grown by 25% year-on-year but it has declined by 2.8% since the previous quarter
Oruka Therapeutics's return on assets has increased by 22% YoY but it has decreased by 2.9% QoQ

Dividends

What is ORKA's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Oruka Therapeutics financials performed over time
Oruka Therapeutics's total liabilities has increased by 43% YoY and by 6% QoQ
The company's total assets rose by 34% YoY and by 3.2% QoQ
The company's debt is 100% lower than its equity
The company's debt has surged by 91% YoY but it fell by 6% QoQ
The company's equity rose by 33% YoY and by 3.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.